Stock Price Quote

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE3188.80-0.15 (0 %)
PREV CLOSE ( ) 3188.95
OPEN PRICE ( ) 3191.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 87417
TODAY'S LOW / HIGH ( )3153.85 3249.50
52 WK LOW / HIGH ( )2065.3 3249.5
NSE3189.150.4 (+0.01 %)
PREV CLOSE( ) 3188.75
OPEN PRICE ( ) 3190.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3189.15 (226)
VOLUME 2302269
TODAY'S LOW / HIGH( ) 3157.75 3249.95
52 WK LOW / HIGH ( )1872.95 3249.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York

NEWS

27Jan Dr. Reddys reports consolidated net lo
Dr. Reddys Laboratories has reported results for third quarter ended Dec..
27Jan Dr. Reddys shines despite reporting co
Dr. Reddys is currently trading at Rs. 3185.10, up by 157.05 points or 5..
06Jan IRB Infrastructure, Vedanta and NLC In
IRB Infrastructure Developershas received NOC from NHAI for transfer of..
04Jan Dr. Reddy’s gets shareholders' nod to
Dr. Reddy's Laboratories has received shareholders' nod for proposed ama..
30Dec Dr. Reddy’s Laboratories launches Sodi
Dr. Reddy's Laboratories has launched Sodium Nitroprusside Injection, 50..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit521712773
Gross Profit 6175 17007
Operating Profit 825025381
Net Sales 30440106255

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  2623.30 (2.79%)
M.Cap ( in Cr)6558.25
Divis Lab (BSE)
peergroup  1946.00 (1.47%)
M.Cap ( in Cr)51660.19
Alembic Pharma (BSE)
peergroup  631.70 (2.75%)
M.Cap ( in Cr)11908.55
Ipca Laboratories (BSE)
peergroup  1243.05 (0.98%)
M.Cap ( in Cr)15706.20
Glaxosmithkline Phar (BSE)
peergroup  1687.80 (0.62%)
M.Cap ( in Cr)28592.35

Shareholding Pattern

MUTUAL FUNDS/UTI 9.29%
FI/BANKS/INSURANCE 5.71%
PROMOTERS 26.76%
NON-INSTITUTION 13.8%
GOVERNMENT 0%
FII 0%

About Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories Ltd. was incorporated in the year 24-02-1984. Its today's share price is 3188.95. Its current market capitalisation stands at Rs 52986.1 Cr. In the latest quarter, company has reported Gross Sales of Rs. 154482 Cr and Total Income of Rs.157857 Cr. The company's management includes Allan Oberman, Sandeep Poddar, Shikha Sharma, Leo Puri, Sridar Iyengar, Prasad R Menon, Kalpana Morparia, Bruce L A Carter, Bharat N Doshi, GV Prasad, K Satish Reddy.

It is listed on the BSE with a BSE Code of 500124 , NSE with an NSE Symbol of DRREDDY and ISIN of INE089A01023. It's Registered office is at 8-2-337,Road No. 3,Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are A Rama Chandra Rao & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X